Ranbaxy Laboratories Ltd. said its wholly-owned subsidiary Ranbaxy Pharmaceuticals Inc. had launched an authorized generic version of Caduet in the Us market, as part of an agreement with Pfizer Inc.
Ranbaxy launches authorized generic version of Caduet in the US